Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |